Rosuvastatin-regulated post-translational phosphoproteome in human umbilical vein endothelial cells

Bin Huang, Chien Hsing Wu, Fu An Li, Shih Shin Liang, Ying Hua Shieh, Ling Danny Wang

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Statins, 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors, are widely prescribed as cholesterol-lowering drugs. Statins have recently been found to have pleiotropic effects that are independent of their lipid-lowering properties. Phosphorylation of serine, threonine, and tyrosine residues of functional proteins are considered to be important in the endothelial signaling cascade. In this study, protein phosphorylation status in human umbilical vein endothelial cells (ECs) after rosuvastatin treatment was examined. The proteins were collected from rosuvastatin-treated ECs and then the phosphorylated peptides purified by a Fe3+-immobilized metal-affinity chromatography bead system were examined by liquid chromatography-tandem mass spectrometry analysis. Alterations of the phosphorylation status of proteins were noticed after rosuvastatin treatment. There were 277 and 530 phosphorylated proteins identified from the control and rosuvastatin-treated ECs, respectively. Among those proteins, T78, in addition to S156 of the Ras-GTPase-activating protein, was phosphorylated after rosuvastatin treatment. Rosuvastatin reduced the phosphorylation of Y455 in HSP90 protein. Decreased phosphorylation of T211 with a concurrent increase in the T291 phosphorylation of Akt1 was observed under rosuvastatin treatment. Increased S633 phosphorylation was detected in endothelial nitric oxide synthase. Western blot analysis further showed an earlier and greater S633 phosphorylation than that of S1177 in endothelial nitric oxide synthase after rosuvastatin treatment. Changes in the phosphorylation status of these proteins may alter the protein's function and affect endothelial physiology. The current study provides new insights leading to a better understanding of the pleiotropic effects of statins on the vascular system

Original languageEnglish
Pages (from-to)347-352
Number of pages6
JournalKaohsiung Journal of Medical Sciences
Volume29
Issue number7
DOIs
Publication statusPublished - Jul 2013

Fingerprint

Human Umbilical Vein Endothelial Cells
Phosphorylation
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Proteins
Nitric Oxide Synthase Type III
Endothelial Cells
ras GTPase-Activating Proteins
Far-Western Blotting
Rosuvastatin Calcium
Threonine
Tandem Mass Spectrometry
Affinity Chromatography
Liquid Chromatography
Serine
Blood Vessels
Tyrosine
Oxidoreductases
Metals
Cholesterol
Lipids

Keywords

  • Human umbilical vein endothelial cells
  • Phosphorylation
  • Pleiotropic effect
  • Proteomics
  • Rosuvastatin

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Rosuvastatin-regulated post-translational phosphoproteome in human umbilical vein endothelial cells. / Huang, Bin; Wu, Chien Hsing; Li, Fu An; Liang, Shih Shin; Shieh, Ying Hua; Wang, Ling Danny.

In: Kaohsiung Journal of Medical Sciences, Vol. 29, No. 7, 07.2013, p. 347-352.

Research output: Contribution to journalArticle

Huang, Bin ; Wu, Chien Hsing ; Li, Fu An ; Liang, Shih Shin ; Shieh, Ying Hua ; Wang, Ling Danny. / Rosuvastatin-regulated post-translational phosphoproteome in human umbilical vein endothelial cells. In: Kaohsiung Journal of Medical Sciences. 2013 ; Vol. 29, No. 7. pp. 347-352.
@article{62955d5dbee04bc3b67fa0865267aa2c,
title = "Rosuvastatin-regulated post-translational phosphoproteome in human umbilical vein endothelial cells",
abstract = "Statins, 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors, are widely prescribed as cholesterol-lowering drugs. Statins have recently been found to have pleiotropic effects that are independent of their lipid-lowering properties. Phosphorylation of serine, threonine, and tyrosine residues of functional proteins are considered to be important in the endothelial signaling cascade. In this study, protein phosphorylation status in human umbilical vein endothelial cells (ECs) after rosuvastatin treatment was examined. The proteins were collected from rosuvastatin-treated ECs and then the phosphorylated peptides purified by a Fe3+-immobilized metal-affinity chromatography bead system were examined by liquid chromatography-tandem mass spectrometry analysis. Alterations of the phosphorylation status of proteins were noticed after rosuvastatin treatment. There were 277 and 530 phosphorylated proteins identified from the control and rosuvastatin-treated ECs, respectively. Among those proteins, T78, in addition to S156 of the Ras-GTPase-activating protein, was phosphorylated after rosuvastatin treatment. Rosuvastatin reduced the phosphorylation of Y455 in HSP90 protein. Decreased phosphorylation of T211 with a concurrent increase in the T291 phosphorylation of Akt1 was observed under rosuvastatin treatment. Increased S633 phosphorylation was detected in endothelial nitric oxide synthase. Western blot analysis further showed an earlier and greater S633 phosphorylation than that of S1177 in endothelial nitric oxide synthase after rosuvastatin treatment. Changes in the phosphorylation status of these proteins may alter the protein's function and affect endothelial physiology. The current study provides new insights leading to a better understanding of the pleiotropic effects of statins on the vascular system",
keywords = "Human umbilical vein endothelial cells, Phosphorylation, Pleiotropic effect, Proteomics, Rosuvastatin",
author = "Bin Huang and Wu, {Chien Hsing} and Li, {Fu An} and Liang, {Shih Shin} and Shieh, {Ying Hua} and Wang, {Ling Danny}",
year = "2013",
month = "7",
doi = "10.1016/j.kjms.2012.06.002",
language = "English",
volume = "29",
pages = "347--352",
journal = "Gaoxiong yi xue ke xue za zhi = The Kaohsiung journal of medical sciences",
issn = "1607-551X",
publisher = "高雄醫學大學",
number = "7",

}

TY - JOUR

T1 - Rosuvastatin-regulated post-translational phosphoproteome in human umbilical vein endothelial cells

AU - Huang, Bin

AU - Wu, Chien Hsing

AU - Li, Fu An

AU - Liang, Shih Shin

AU - Shieh, Ying Hua

AU - Wang, Ling Danny

PY - 2013/7

Y1 - 2013/7

N2 - Statins, 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors, are widely prescribed as cholesterol-lowering drugs. Statins have recently been found to have pleiotropic effects that are independent of their lipid-lowering properties. Phosphorylation of serine, threonine, and tyrosine residues of functional proteins are considered to be important in the endothelial signaling cascade. In this study, protein phosphorylation status in human umbilical vein endothelial cells (ECs) after rosuvastatin treatment was examined. The proteins were collected from rosuvastatin-treated ECs and then the phosphorylated peptides purified by a Fe3+-immobilized metal-affinity chromatography bead system were examined by liquid chromatography-tandem mass spectrometry analysis. Alterations of the phosphorylation status of proteins were noticed after rosuvastatin treatment. There were 277 and 530 phosphorylated proteins identified from the control and rosuvastatin-treated ECs, respectively. Among those proteins, T78, in addition to S156 of the Ras-GTPase-activating protein, was phosphorylated after rosuvastatin treatment. Rosuvastatin reduced the phosphorylation of Y455 in HSP90 protein. Decreased phosphorylation of T211 with a concurrent increase in the T291 phosphorylation of Akt1 was observed under rosuvastatin treatment. Increased S633 phosphorylation was detected in endothelial nitric oxide synthase. Western blot analysis further showed an earlier and greater S633 phosphorylation than that of S1177 in endothelial nitric oxide synthase after rosuvastatin treatment. Changes in the phosphorylation status of these proteins may alter the protein's function and affect endothelial physiology. The current study provides new insights leading to a better understanding of the pleiotropic effects of statins on the vascular system

AB - Statins, 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors, are widely prescribed as cholesterol-lowering drugs. Statins have recently been found to have pleiotropic effects that are independent of their lipid-lowering properties. Phosphorylation of serine, threonine, and tyrosine residues of functional proteins are considered to be important in the endothelial signaling cascade. In this study, protein phosphorylation status in human umbilical vein endothelial cells (ECs) after rosuvastatin treatment was examined. The proteins were collected from rosuvastatin-treated ECs and then the phosphorylated peptides purified by a Fe3+-immobilized metal-affinity chromatography bead system were examined by liquid chromatography-tandem mass spectrometry analysis. Alterations of the phosphorylation status of proteins were noticed after rosuvastatin treatment. There were 277 and 530 phosphorylated proteins identified from the control and rosuvastatin-treated ECs, respectively. Among those proteins, T78, in addition to S156 of the Ras-GTPase-activating protein, was phosphorylated after rosuvastatin treatment. Rosuvastatin reduced the phosphorylation of Y455 in HSP90 protein. Decreased phosphorylation of T211 with a concurrent increase in the T291 phosphorylation of Akt1 was observed under rosuvastatin treatment. Increased S633 phosphorylation was detected in endothelial nitric oxide synthase. Western blot analysis further showed an earlier and greater S633 phosphorylation than that of S1177 in endothelial nitric oxide synthase after rosuvastatin treatment. Changes in the phosphorylation status of these proteins may alter the protein's function and affect endothelial physiology. The current study provides new insights leading to a better understanding of the pleiotropic effects of statins on the vascular system

KW - Human umbilical vein endothelial cells

KW - Phosphorylation

KW - Pleiotropic effect

KW - Proteomics

KW - Rosuvastatin

UR - http://www.scopus.com/inward/record.url?scp=84879100719&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84879100719&partnerID=8YFLogxK

U2 - 10.1016/j.kjms.2012.06.002

DO - 10.1016/j.kjms.2012.06.002

M3 - Article

VL - 29

SP - 347

EP - 352

JO - Gaoxiong yi xue ke xue za zhi = The Kaohsiung journal of medical sciences

JF - Gaoxiong yi xue ke xue za zhi = The Kaohsiung journal of medical sciences

SN - 1607-551X

IS - 7

ER -